Key Takeaways
IMPACT Therap-B (07630.HK) shares surged more than 60 percent in grey market trading on Friday, signaling strong investor appetite ahead of the company’s public debut on the Hong Kong Stock Exchange.
The clinical-stage biotechnology company is scheduled to officially list on the Main Board on Monday, May 13.
Data from Futu’s grey market showed the stock closing at $32.16, a 60 percent jump from its listing price. The session saw a high of $52 and a low of $26, with 3.21 million shares changing hands for a total turnover of $99.77 million. Excluding fees, this performance translated to a book gain of $2,412 per board lot of 200 shares.
Activity on the PhillipMart grey market was similarly robust. The stock opened at $22 and closed at $32.3, representing a 60.7 percent increase from its offer price. Trading volume reached 2.57 million shares with a turnover of $79.8 million, resulting in a per-lot book gain of $2,440.
The strong pre-market performance suggests a positive reception for the IPO. First-day trading on May 13 will be a key test of institutional and retail demand for the biotechnology firm.
This article is for informational purposes only and does not constitute investment advice.
